Pine Labs and Pfizer Report Profit Growth in Q1 FY27 with Revenue Increases
Pine Labs reported a 20% rise in Q1 FY27 revenue to approximately Rs 737 crore and a fourfold increase in consolidated net profit to Rs 19.57 crore, driven by growth in its issuing and acquiring platform and reduced employee stock-option costs. Meanwhile, Pfizer Ltd posted a 6.6% increase in standalone net profit to Rs 204.47 crore, with revenue rising 8.3% to Rs 653.17 crore in the same quarter. Both companies saw expenses grow at a slower pace than income, supporting profit gains.
First-hand measurement across 7 sources
We measured how 7 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (62/100). Lens Score 37/100.
Outlets measured: economictimes, news18, businessstandard, businessstandard, businessstandard, freepressjournal, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–72/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 28 Jul, 08:46 am. Other outlets followed.